Infant Massage for Lymphedema and Comfort in Preterm Newborns

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28-37
SponsorErzurum Technical University

About this trial

This randomized controlled trial investigates the effectiveness of infant massage in reducing symptoms of immobilization-related lymphedema and improving comfort in preterm newborns hospitalized in the Neonatal Intensive Care Unit (NICU). Preterm infants frequently develop lymphedema due to their immature circulatory systems and prolonged lack of movement.

The study compares two groups of infants: one receiving standard care and another receiving a daily 15-minute massage therapy session for 14 consecutive days in addition to standard care. Researchers will evaluate the impact of the massage by measuring the circumference of the infants' wrists, elbows, ankles, and knees to assess fluid reduction. Additionally, the infants' comfort levels will be assessed using the Premature Infant Comfort Scale (PICS). The goal is to determine if massage can serve as a safe, non-invasive method to manage lymphedema and reduce distress in this vulnerable population.

Eligibility criteria

Qualifiers

Clinical diagnosis of lymphedema.

Hemodynamic and clinical stability.

No current or recent (within 24 hours) administration of analgesic or sedative medications that could mask comfort assessments.

Intact skin integrity with no contraindications for topical massage.

Disqualifiers

Major congenital anomalies.

Severe respiratory, cardiac, or neurological instability during the study period.

Any acute medical contraindication identified by the attending neonatologist.

Trial design

Treatments tested in this trial

  • Infant Massage Group

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Erzurum Technical University

Lead sponsor